Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 13Ovarian Neoplasms 9Peritoneal Neoplasms 8Carcinoma, Ovarian Epithelial 6Fallopian Tube Neoplasms 5Colorectal Neoplasms 4Mesothelioma 2Carcinoma 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stage â…¢ Gastric Cancer 1Stage IV Gastric Cancer With Metastasis 1Pseudomyxoma Peritonei 1Pleural Effusion 1Peritoneal Cancer 1Pancreatic Neoplasms 1Ovarian Cancer Recurrent 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Locally Advanced Colorectal Cancer 1Hyperthermic Intraperitoneal Chemotherapy 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Exploratory Behavior 1Drug-Related Side Effects and Adverse Reactions 1Ascites 1Appendiceal Neoplasms 1Advanced Gastric Adenocarcinoma 1

Interventions

camrelizumab 2spartalizumab 1apatinib 1S 1 (combination) 1Neoadjuvant Therapy 1Hyperthermic Intraperitoneal Chemotherapy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Gastric Adenocarcinoma × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT02240524 2014-09-15

HIPEC

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Phase 3 Unknown
582 enrolled
Gastrointestinal

Advanced Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡